This review evaluated the impact of depression screening instruments and depression treatment in patients with cardiovascular disease, concluding that depression treatment is associated with a modest improvement in depressive symptoms but not cardiac outcomes. It found no trials on the effects of depression screening on depressive symptoms or cardiac outcomes. Given the evidence presented, the authors' conclusions appear appropriate.
Study selection
Studies that selected patients on the basis of clinical characteristics of cardiovascular disease and identified major depressive disorder (MDD) using internationally recognised criteria were eligible for inclusion in the review.
Studies evaluating the accuracy of screening instruments were included if they compared the instrument to a valid standard and reported data that allowed calculation of sensitivity, specificity and positive and negative predictive values. Studies evaluating the effect of depression treatment on depression and cardiac outcomes were eligible if they were randomised controlled trials (RCTs) comparing pharmacological, psychotherapeutic or other interventions for MDD with placebo or usual care in patients in cardiovascular care settings. Evaluated treatments included fluoxetine, sertraline, mirtazapine, citalopram, interpersonal psychotherapy and clinical management, 'active treatment' and cognitive behavioural therapy.
Studies evaluating the effect of screening on depression and cardiac outcomes were eligible if they were RCTs or prospective studies comparing depression identification, depression treatment rates or depressive or cardiac outcomes between cardiovascular disease patients who did or did not undergo screening.
Study selection was independently undertaken by two reviewers, with disagreements resolved by consensus.
Assessment of study quality
Studies were evaluated according to criteria described by the US Preventive Services Task Force, with specific studies evaluated on the basis of their quality in relation to the key question being addressed. Two reviewers independently assessed validity, with disagreements resolved by consensus.
Data extraction
Two reviewers independently extracted data from included studies. Disagreements were resolved by consensus. For studies of the accuracy of screening instruments, data were extracted on sensitivity, specificity and positive and negative predictive values with 95% confidence intervals (CIs). For depression treatment studies, effects were
